Standard BioTools

Standard BioTools Inc. (NASDAQ: LAB), formerly known as Fluidigm Corp., is a life science tools company headquartered in South San Francisco, California, that delivers leading proteomic and multi-omic solutions enabling researchers to discover unique biological insights not accessible by other technologies. The company's core franchises span mass cytometry (CyTOF systems), imaging mass cytometry (Hyperion), and microfluidics-based genomics (Biomark). These platforms support high-parameter single-cell proteomics, spatial proteomics, NGS library preparation, genotyping, gene expression analysis, and pathogen detection. Standard BioTools serves academic, government, pharmaceutical, biotechnology, and clinical research laboratories worldwide. In 2026, the company announced a merger agreement with Treeline Biosciences.